- Home
- GERN vs CDE Comparison
GERN vs CDE Comparison
Compare GERN & CDE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GERN
- CDE
- Stock Information
- Founded
- GERN 1990
- CDE 1928
- Country
- GERN United States
- CDE United States
- Employees
- GERN N/A
- CDE N/A
- Industry
- GERN Biotechnology: Pharmaceutical Preparations
- CDE Precious Metals
- Sector
- GERN Health Care
- CDE Basic Materials
- Exchange
- GERN Nasdaq
- CDE Nasdaq
- Market Cap
- GERN 2.5B
- CDE 2.6B
- IPO Year
- GERN 1996
- CDE N/A
- Fundamental
- Price
- GERN $3.93
- CDE $6.32
- Analyst Decision
- GERN Strong Buy
- CDE Strong Buy
- Analyst Count
- GERN 10
- CDE 4
- Target Price
- GERN $7.05
- CDE $7.81
- AVG Volume (30 Days)
- GERN 6.7M
- CDE 8.7M
- Earning Date
- GERN 11-07-2024
- CDE 11-06-2024
- Dividend Yield
- GERN N/A
- CDE N/A
- EPS Growth
- GERN N/A
- CDE N/A
- EPS
- GERN N/A
- CDE N/A
- Revenue
- GERN $29,480,000.00
- CDE $1,010,652,000.00
- Revenue This Year
- GERN $32,021.10
- CDE $32.61
- Revenue Next Year
- GERN $298.14
- CDE $39.85
- P/E Ratio
- GERN N/A
- CDE N/A
- Revenue Growth
- GERN 9199.68
- CDE 31.38
- 52 Week Low
- GERN $1.64
- CDE $2.42
- 52 Week High
- GERN $5.34
- CDE $7.72
- Technical
- Relative Strength Index (RSI)
- GERN 46.32
- CDE 44.84
- Support Level
- GERN $3.75
- CDE $6.95
- Resistance Level
- GERN $4.05
- CDE $7.38
- Average True Range (ATR)
- GERN 0.16
- CDE 0.30
- MACD
- GERN -0.01
- CDE -0.04
- Stochastic Oscillator
- GERN 39.13
- CDE 13.85
About GERN Geron Corporation
Geron Corp is a clinical-stage biopharmaceutical company focused on the research and development of cancer treatments. The company's drug in development, Imelstat, is being tested for the treatment of myelodysplastic syndromes, which are disorders of the blood, and myelofibrosis, which is a rare blood cancer affecting bone marrow. The company earns revenue through collaboration agreements, milestones, royalties, and licensing arrangements. Geron possesses various rights to this drug. The company operates as a single segment being, the development of therapeutic products for oncology.
About CDE Coeur Mining Inc.
Coeur Mining Inc is a metals producer focused on mining precious minerals in the Americas. It is involved in the discovery and mining of gold and silver and generates the vast majority of revenue from the sale of these precious metals. The operating mines of the company are palmarejo, Rochester, Wharf, and Kensington. Its projects are located in the United States, Canada Mexico, and North America.